This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003;33(1):71-8.

doi: 10.1385/IJGC:33:1:71.

Transgenic models of pancreatic cancer

Andrew M Lowy¹

Affiliations

PMID: 12909739
DOI: 10.1385/IJGC:33:1:71

Review

Transgenic models of pancreatic cancer

Andrew M Lowy. Int J Gastrointest Cancer. 2003.

. 2003;33(1):71-8.

doi: 10.1385/IJGC:33:1:71.

Author

Andrew M Lowy¹

Affiliation

¹ Division of Surgical Oncology, University of Cincinnati College of Medicine, 234 Goodman Street, Cincinnati, OH 45219-0772, USA. lowyam@uc.edu

PMID: 12909739
DOI: 10.1385/IJGC:33:1:71

No abstract available

PubMed Disclaimer

Similar articles

Animal models of exocrine pancreatic cancer.
Hotz HG, Hines OJ, Foitzik T, Reber HA. Hotz HG, et al. Int J Colorectal Dis. 2000 Jun;15(3):136-43. doi: 10.1007/s003840000229. Int J Colorectal Dis. 2000. PMID: 10954185 Review.
Evaluation and utilization of transgenic animal models in studies of pancreatic cancer. Pancreas Cancer Working Group.
[No authors listed] [No authors listed] Pancreas. 1987;2(4):470-2. Pancreas. 1987. PMID: 3650908 No abstract available.
Models of Exocrine Pancreatic Neoplasms in Transgenic Mice.
Longnecker DS. Longnecker DS. Comp Med. 2004 Feb;54(1):18-21. Comp Med. 2004. PMID: 15382335 Review. No abstract available.
Gene alterations in rodent and human tumors of the exocrine and endocrine pancreas.
Scarpelli DG, Cerny WL, Mangold KA. Scarpelli DG, et al. Prog Clin Biol Res. 1992;376:223-43. Prog Clin Biol Res. 1992. PMID: 1326770 Review. No abstract available.
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, Kloppel G, Lauwers GY, Longnecker DS, Luttges J, Maitra A, Offerhaus GJ, Pérez-Gallego L, Redston M, Tuveson DA. Hruban RH, et al. Cancer Res. 2006 Jan 1;66(1):95-106. doi: 10.1158/0008-5472.CAN-05-2168. Cancer Res. 2006. PMID: 16397221

See all similar articles

Cited by

Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague-Dawley rats.
Tan XG, Yang ZL, Yang LP, Miao XY. Tan XG, et al. World J Surg Oncol. 2014 Feb 6;12:32. doi: 10.1186/1477-7819-12-32. World J Surg Oncol. 2014. PMID: 24502441 Free PMC article.
Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer.
Liao JD, Adsay NV, Khannani F, Grignon D, Thakur A, Sarkar FH. Liao JD, et al. Histol Histopathol. 2007 Jun;22(6):661-76. doi: 10.14670/HH-22.661. Histol Histopathol. 2007. PMID: 17357096 Free PMC article. Review.
Characterization of pancreatic lesions from MT-tgf alpha, Ela-myc and MT-tgf alpha/Ela-myc single and double transgenic mice.
Liao DJ, Wang Y, Wu J, Adsay NV, Grignon D, Khanani F, Sarkar FH. Liao DJ, et al. J Carcinog. 2006 Jul 5;5:19. doi: 10.1186/1477-3163-5-19. J Carcinog. 2006. PMID: 16822304 Free PMC article.

References

1. Gastroenterology. 2001 Jun;120(7):1720-8 - PubMed
1. Cancer Res. 1984 Feb;44(2):717-26 - PubMed
1. Cancer Res. 1992 Aug 15;52(16):4507-13 - PubMed
1. N Engl J Med. 1992 Feb 13;326(7):455-65 - PubMed
1. Lab Invest. 1997 Jan;76(1):117-28 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information